News Releases
-
July 6, 2020
AMP German Cannabis Group to begin medical cannabis imports from the Netherlands
ERFURT and BERLIN, Germany, July 6th, 2020 – AMP German Cannabis Group Inc. (“AMP” o...
-
June 29, 2020
AMP German Cannabis Group announces AGM results and appointment of new CFO
ERFURT and BERLIN, Germany, June 29th, 2020 – AMP German Cannabis Group Inc. (“AMP” ...
-
June 17, 2020
AMP German Cannabis Group Announces Stock Option Grant
ERFURT and BERLIN, Germany, June 17th, 2020 – AMP German Cannabis Group Inc. (“AMP” ...
-
June 8, 2020
AMP German Cannabis Group to develop medical cannabis brands for the German market
AMP is fully licenced to import medical cannabis from Europe and other countries Building ...
-
June 6, 2020
AMP German Cannabis Group provides Netherlands import update
ERFURT and BERLIN, Germany, June 5th, 2020 – AMP German Cannabis Group Inc. (“AMP” o...
-
June 2, 2020
AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session
ERFURT, Germany and BERLIN, June 2, 2020 – AMP German Cannabis Group Inc. (R...
-
April 14, 2020
AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany
BERLIN, Germany, April 14, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Co...
-
April 3, 2020
AMP German Cannabis Group Announces Trade Financing for the Import of EU-GMP Medical Cannabis into Germany
BERLIN, Germany, April 3rd, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX)...
-
March 9, 2020
AMP German Cannabis Group Receives Import Licence for Medical Cannabis for imports from European Union Countries
BERLIN, Germany, March 9, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “C...
-
March 7, 2020
AMP German Cannabis Group Closes First Tranche of Non-Brokered Private Placement
BERLIN, Germany, March 6th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX)...
-
January 15, 2020
AMP German Cannabis Group Provides Corporate Update
BERLIN, Germany, January 15th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: X...
-
January 8, 2020
AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business
BERLIN, Germany, January 8, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “C...
-
November 18, 2019
AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia
Berlin and Erfurt, Germany – November 18, 2019 –– AMP German Cannabis Group Inc....
-
October 15, 2019
AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany
AMP to supply the growing Germany market with pharmaceutical medical cannabis imported fro...
-
October 10, 2019
AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany
BERLIN, Germany, October 10, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE: ...
-
October 8, 2019
AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany
BERLIN, Germany, October 8, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE: X...
-
September 17, 2019
AMP German Cannabis Group Supplier, Pure Life Cannabis, Completes EU-GMP Gap Analysis
BERLIN, Germany, September 17, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE...
-
-
September 4, 2019
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry
BERLIN, Germany, September 4, 2019 – AMP German Cannabis Group Inc. (“AMP” o...
-
August 22, 2019
Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange
BERLIN, Germany, August 22, 2019 – Chinook Tyee Industry Limited (“Chinook” ...
-
June 15, 2019
Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement
Chinook Insiders are the largest investors in the Series A financing as its German subsidi...
-
May 29, 2019
Chinook joins forces with a leading German pharmaceutical consulting company
Chinook establishes EU-GMP standards for its imports of medical cannabis to Germany fro...
-
May 8, 2019
Chinook Announces Stock Option Grant
BERLIN, Germany, May 8th, 2019 – Chinook Tyee Industry Limited (“Chinook”) (...
-
May 6, 2019
Chinook Announces Private Placement Financing
BERLIN, Germany, May 6th, 2019 – Chinook Tyee Industry Limited (“Chinook”) (...
-
May 3, 2019
Chinook Announces Dual Listing on the Frankfurt Stock Exchange
BERLIN, GERMANY, May 3rd, 2019 | Chinook Tyee Industry Limited (“Chinook”) (TS...
-
February 7, 2019
Chinook’s subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany
ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ – AMP Alternative Medical Prod...
-
February 5, 2019
Update on Chinook’s Investments in Germany
BERLIN, Feb. 5, 2019 /CNW/ – Chinook Tyee Industry Limited (“Chinook”)...
-
January 2, 2019
Chinook Announces New Directors and Officers
ERFURT, GERMANY, January 2nd, 2019 | Chinook Tyee Industry Limited (the “CompanyR...
-
December 3, 2018
Chinook subsidiary, AMP Alternative Medical Products, receives €500,000 Series B financing to fund its medical cannabis business in Germany
ERFURT, Germany, Dec. 3, 2018 /CNW/ – Chinook Tyee Industry Limited (“Chino...